help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-83-3-585
Endocrinology Vol. 83, No. 3 585-591
Copyright © 1968 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BARKER, K. L.
Right arrow Articles by ANDERSON, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BARKER, K. L.
Right arrow Articles by ANDERSON, J. M.

Displacement of Estradiol-17β from the Uterus by Estradiol-17{alpha}: Effect on Template Capacity of Uterine Chromatin

KENNETH L. BARKER1 and JOHN M. ANDERSON2

Departments of Obstetrics and Gynecology and of Biochemistry, University of Nebraska, College of Medicine Omaha, Nebraska 68105

Abstract

Administration of 6,7-3H-estradiol- 17β to mature ovariectomized rats results in the labeling of 2 pools of estradiol-17β in the uterus. Half-lives of the 2 pools are 0.7 and 5 hr. Intraluminal (IL) uterine application of 10 µg of estradiol-17{alpha} 6 hr after administration of 3Hestradiol- 17β is capable of enhancing the rate of displacement of the previously bound active estrogen from the uterus. By the 12th hr the uterine levels are 30-50% less than in saline treated controls. The reduced estradiol-17β content is reflected in the relative labeling of uterine chromatin prepared from the 2 groups. When assayedassayed for its capacity to serve as a template for DNA-dependent RNA polymerase, it was found that treatment with estradiol-17{alpha} prevented the additional increase in template capacity of uterine chromatin normally observed to occur between the 6th and 12th hr after treatment with estradiol-17β. These results suggest that estradiol- 17{alpha} and perhaps other estrogenic compounds with subdued biological activity may well able to inhibit certain estrogen induced uterine responses which are in progress at the time treatment. (Endocrinology 83: 585, 1968)

Footnotes

Population Council and (HD-02851) from the USPHS.

1 Career Development Awardee (HD-038656), National Institute of Child Health and Human Development.

2 Predoctoral Fellow in the Reproductive Biology Training Program (USPHS, 2T1HD-18-06) of Department of Obstetrics and Gynecology, University of Nebraska College of Medicine.

Received December 15, 1967.




This article has been cited by other articles:


Home page
ScienceHome page
G. L. Whitson and F. A. Murray
Cell Culture of Mammalian Endometrium and Synthesis of Blastokinin in vitro
Science, February 15, 1974; 183(4125): 668 - 670.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1968 by The Endocrine Society